KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2025)

Evolent Health has reported Amortization of Deferred Charges over the past 9 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $2.0 million for Q4 2025, up 70.18% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (up 41.39% YoY), and the annual figure for FY2025 was $6.8 million, up 41.6%.
  • Amortization of Deferred Charges for Q4 2025 was $2.0 million at Evolent Health, up from $106000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for EVH hit a ceiling of $8.1 million in Q4 2021 and a floor of -$12.5 million in Q4 2022.
  • Median Amortization of Deferred Charges over the past 5 years was $490000.0 (2022), compared with a mean of $653250.0.
  • Biggest five-year swings in Amortization of Deferred Charges: soared 2400.0% in 2021 and later tumbled 253.58% in 2022.
  • Evolent Health's Amortization of Deferred Charges stood at $8.1 million in 2021, then tumbled by 253.58% to -$12.5 million in 2022, then skyrocketed by 66.36% to -$4.2 million in 2023, then surged by 128.48% to $1.2 million in 2024, then surged by 70.18% to $2.0 million in 2025.
  • The last three reported values for Amortization of Deferred Charges were $2.0 million (Q4 2025), $106000.0 (Q3 2025), and $441000.0 (Q2 2025) per Business Quant data.